BRIM Biotechnology, Inc. (TPE:6885)
Taiwan · Delayed Price · Currency is TWD 20.70
0.00 (0.00%)
At close: May 29, 2026
BRIM Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -431.89 | -436.45 | -315.47 | -688.02 | -274.28 | -105.45 |
Depreciation & Amortization | 44.55 | 42.19 | 8.42 | 5.21 | 3.97 | 3.82 |
Other Amortization | 0.9 | 0.9 | 0.83 | 0.2 | - | - |
Loss (Gain) From Sale of Assets | - | - | - | -0.01 | - | - |
Loss (Gain) From Sale of Investments | - | - | - | - | - | -32.87 |
Loss (Gain) on Equity Investments | 13.61 | 13.47 | 27.03 | 24.59 | 62.62 | 47.94 |
Stock-Based Compensation | 32.27 | 36.02 | 39.17 | 47.78 | 35.32 | 7.07 |
Other Operating Activities | 1.01 | 4.1 | -13.82 | -4.38 | 0.24 | 0.27 |
Change in Accounts Receivable | -0.49 | -0.47 | - | -1.41 | -0.32 | -0.01 |
Change in Inventory | 0.25 | 0.16 | - | - | - | - |
Change in Accounts Payable | -0.56 | -0.66 | - | 19.67 | 4.14 | -31.77 |
Change in Unearned Revenue | 2.12 | 0.83 | - | - | - | -1.12 |
Change in Other Net Operating Assets | -19.89 | 10.73 | -25.39 | -0.51 | -3.57 | -0.45 |
Operating Cash Flow | -358.11 | -329.17 | -279.24 | -596.89 | -171.87 | -112.57 |
Capital Expenditures | -2.51 | -0.8 | -2.9 | -2.26 | -1.11 | -0.78 |
Sale of Property, Plant & Equipment | - | - | - | 0.01 | - | - |
Cash Acquisitions | 4.4 | 4.4 | - | - | - | - |
Sale (Purchase) of Intangibles | -324.24 | -324.24 | -77.08 | -1.44 | -0.11 | - |
Investment in Securities | 346.79 | 970.04 | -585.18 | -747.63 | 23.84 | 119.34 |
Other Investing Activities | 0.55 | 0.54 | -0.32 | -0.11 | 0 | -0 |
Investing Cash Flow | 24.99 | 649.94 | -665.48 | -751.43 | 22.63 | 118.56 |
Short-Term Debt Repaid | - | -16 | - | - | - | - |
Long-Term Debt Repaid | - | -9.57 | -4.16 | -4.18 | -3.68 | -3.6 |
Total Debt Repaid | -27.09 | -25.57 | -4.16 | -4.18 | -3.68 | -3.6 |
Net Debt Issued (Repaid) | -27.09 | -25.57 | -4.16 | -4.18 | -3.68 | -3.6 |
Issuance of Common Stock | 1.5 | 0.53 | 503.64 | 1,463 | 591.16 | 314.33 |
Other Financing Activities | 0.02 | 0.02 | - | - | - | - |
Financing Cash Flow | -25.57 | -25.02 | 499.49 | 1,458 | 587.49 | 310.73 |
Foreign Exchange Rate Adjustments | -0.12 | -0.08 | - | - | - | - |
Net Cash Flow | -358.81 | 295.67 | -445.24 | 110.01 | 438.24 | 316.72 |
Free Cash Flow | -360.62 | -329.97 | -282.14 | -599.15 | -172.98 | -113.35 |
Free Cash Flow Margin | -4390.88% | -6010.38% | -84726.73% | -665723.33% | -32885.74% | -31485.83% |
Free Cash Flow Per Share | -2.75 | -2.51 | -2.42 | -5.96 | -2.43 | -1.91 |
Cash Interest Paid | 0.46 | 0.46 | 0.09 | 0.15 | 0.08 | 0.11 |
Cash Income Tax Paid | 0.03 | 0.03 | - | -0.07 | -0.13 | -0.05 |
Levered Free Cash Flow | -867.83 | -840.64 | 50.82 | -371.06 | -97.94 | -81.3 |
Unlevered Free Cash Flow | -867.48 | -840.33 | 50.88 | -370.97 | -97.89 | -81.23 |
Change in Working Capital | -18.57 | 10.59 | -25.39 | 17.75 | 0.25 | -33.34 |